Aimedis is an innovative blockchain-based healthcare ecosystem that focuses on optimizing patient care and streamlining data management, providing a secure decentralized platform for managing medical records and telemedicine services.

Aimedis

MedTech World is a global event management company that organizes an annual investor and entrepreneur conference in the medtech and health tech sector in Malta, along with multiple roadshow events worldwide. It fosters collaboration among stakeholders to enhance healthcare.

MedTech World

Aimedis | 14,842 followers on LinkedIn. We are creating the future of healthcare. | Aimedis is the world&#39;s first real healthcare Metaverse &amp; the world&#39;s first medical data NFT marketplace - eHealth for a new era. We are creating the future of healthcare.

Sheridan Tatsuno

Empowering storytellers, advising and rooting for trailblazers, challenging the status quo.

Kevin Hamilton

Digital Healthcare Humanist & Futurist 💡 | Healthcare Metaverse & AI Pioneer 🌐 | Thought Provoking International & TEDx speaker 🎤 | Inspiring…

Philippe GERWILL

Managing Director at BRI Capital

Yehoshua ‘Jack’ Westover 伍立群

We are excited to provide you with further insight into the development of our Metaverse. Below you will find links to our Youtube channel where we present our various maps in videos. Aimedis Avalon — United Arab Emirates — Release 1.0 Link: https://lnkd.in/eAnpYR4V Aimedis Avalon — Northern Australia — Release 1.0 Link: https://lnkd.in/eJavaF8g Aimedis Avalon — Japan — Release 1.0 Link: https://lnkd.in/eQ5rRqxH Have fun watching #metaverse #healthcare #AI #medicine #medical #doctors #health #ehealth #Web3 #DeSci #NFTs #NFT #VirtualReality #AR #VR #AIMEDIS #AIMX $AIMX #Medtwitter #medstudents #HealthcareRevolution #education #therapies #pharma #HealthTech #MedicalResearch #FutureOfMedicine

Avalon is evidence based ! https://lnkd.in/e_FyD5eV #aimedis #metaverse #ai Jaroslaw Hryniewicki Professor Shafi Ahmed Philippe GERWILL Rafael J. Grossmann, MD, MSHS, FACS Faisal Nawaz Lucas Perez Dr. Martha Boeckenfeld

🎉 Announcement: Aimedis Avalon Launch in Australia 🇦🇺 We are thrilled to announce that Aimedis Avalon is now going live in Australia, in partnership with VOIX, WFNR, Rothschild Wellness Institute, and Avalon Virtual Medical School. This marks a significant milestone as we bring our innovative platform to Australian users. 🚀 Initially, the client version of Aimedis Avalon will be available for those registering with us. To ensure the best experience, please note the following system requirements: Operating System: Windows 64-bit 💻 RAM: 32GB 🧠 Graphics: Geforce 4080 or higher 🎮 We are pleased to offer payment options via credit card 💳 and AIMX 🪙. Get ready to experience the future of healthcare with Aimedis Avalon! 🏥✨ For more information or to register, visit our website. 📲 Professor Shafi Ahmed Philippe GERWILL Ioannis Skalidis MD, PhD Jaroslaw Hryniewicki Jennifer Gangnard, PharmD Sasalet. Kalulu NVIDIA Renee Y. Javier Mendoza MD. PhD Javier M Floren Dr. Ben J. O. El Idrissi, MD Michael Kaldasch, MD Dr. Sana Farid Faisal Nawaz Rafael J. Grossmann, MD, MSHS, FACS Lucas Perez Dr Michael Rothschild MD 🦒

New partnership announcement Aimedis, a global leader in healthcare technology solutions, and Aethir, an innovative pioneer in AI-driven GPU cloud services, are thrilled to announce a strategic partnership aimed at delivering state-of-the-art pixel streaming and AI GPU cloud power to users of Aimedis and Avalon worldwide. This collaboration marks a significant milestone in the healthcare technology landscape, combining Aimedis' comprehensive healthcare platform with Aethir's cutting-edge GPU cloud infrastructure. By leveraging Aethir's robust and scalable GPU cloud solutions, Aimedis will enhance its platform's capabilities, providing unparalleled quality and performance for healthcare professionals and patients alike. Enhancing Healthcare Delivery with Pixel Streaming The integration of Aethir's high-quality pixel streaming technology will enable Aimedis to offer real-time, crystal-clear video consultations, remote diagnostics, and virtual care solutions in the world’s first healthcare metaverse. This technological advancement ensures that healthcare providers can deliver precise and efficient care, regardless of geographic boundaries. Patients will benefit from seamless access to top-tier medical expertise, enhancing the overall patient experience and improving health outcomes. Empowering AI-Driven Insights with GPU Cloud Power Aethir's AI GPU cloud power will supercharge Aimedis' data processing capabilities, enabling advanced AI-driven insights and analytics in real time. This will empower healthcare providers with real-time data analysis, predictive modeling, and personalized treatment plans. The collaboration will drive innovation in areas such as medical imaging, drug discovery, and patient monitoring, paving the way for a new era of AI-enhanced healthcare. Global Reach and Impact With this partnership, Aimedis and Aethir are committed to making high-quality healthcare accessible to users across the globe. The combined strength of Aimedis' healthcare platform and Aethir's GPU cloud infrastructure will provide scalable, reliable, and secure solutions to meet the growing demands of the healthcare industry. About Aethir Aethir is a pioneering company specializing in AI-driven GPU cloud services, providing scalable and high-performance cloud infrastructure solutions for various industries, including healthcare, gaming, and finance. #aimedis #avalon #aethir #gpucloudcomputing #nvidia Aethir NVIDIA Professor Shafi Ahmed Ioannis Skalidis MD, PhD Paul Thind Dr. Ben J. O. El Idrissi, MD Renee Y. Joon S. Park NVIDIA Chelsea Sumner, PharmD, Rph Sasalet. Kalulu Kwame Amaning Jennifer Gangnard, PharmD Michael Rebhan Rafael J. Grossmann, MD, MSHS, FACS Sanofi Boris Valls Guardiola Anca Petre Carina Kaiser Maik Lange Muhammed Fafis Dr. Sana Farid Bruce Blausen Faisal Nawaz Philippe GERWILL Jack Resnick Ian Dorr

We are thrilled to announce that AIMEDIS is now a proud member of the Sanofi Innovation Ecosystem Platform with a Sanofi Partnership! 🎉 Joining this prestigious program marks yet another significant milestone in our journey as a reputable service provider in the pharmaceutical industry. We are immensely grateful for the trust and confidence shown in us by Sanofi, a leading innovator in healthcare. Joining the Sanofi Innovation Ecosystem Platform means big things for us. We're getting seen by Sanofi's teams worldwide – that's over 100 countries and about 100,000 employees! It's our chance to show off what we do best and prove our value. Being part of this platform isn't just about visibility; it's about making meaningful connections that make a real difference. We are eager to leverage this partnership to its fullest potential, collaborating with Sanofi to shape the future of healthcare and deliver solutions that benefit patients worldwide. Thank you to Sanofi , Sasalet. Kalulu and Jennifer Gangnard, PharmD for this incredible opportunity to an exciting journey ahead! #aimedis #avalon Professor Shafi Ahmed Philippe GERWILL Ioannis Skalidis MD, PhD Jennifer Gangnard, PharmD Ian Dorr Dr. Ben J. O. El Idrissi, MD Javier Mendoza MD. PhD Javier M Floren Maik Lange Michael Rebhan John Nosta Audrey Derveloy Guy Vallancien Anca Petre Jesus del Valle Faisal Nawaz Sanofi Alex Cahana, MD Dr. Sana Farid Bruce Blausen

Aimedis is happy to announce that a second medical study, proving that Avalon's MRI simulation environment can successfully lower distress and claustrophobia in a cardiac MRI, has been published: #aimedis #avalon #healthcaremetaverse #futureofhealthcare https://lnkd.in/e4mzZfY4 Javier Mendoza MD. PhD Professor Shafi Ahmed Philippe Philippe GERWILL Ioannis Skalidis Dr Faisal Nawaz Dr. Ben J. O. El Idrissi, MD Jaroslaw Hryniewicki Alex Cahana, MD Bradley C. Anca Petre Jennifer Gangnard, PharmD Lucas Perez Javier M Floren Ingrid Andersson Bernard E. Bulwer, M.D., MSc, FASE Dr. Sana Farid Lisa Thomlinson Raees Tonse, MD, MBA Dylan Attard MD, MRCSI, MEnt. Rafael J. Grossmann, MD, MHDS, FACS John Nosta Michael Kaldasch, MD

AI, Web3, and Healthcare: can this be the solution to longevity?h Let's discuss this with @oceanprotocol and @Brainstemhealth today at 6pm CET, 5pm BST in our dedicated AMA on X.com . Set your reminders and join us as we talk about the future. @Wanderclyffe1 @andreaarmanni2 @ShafiAhmed5 @MJKaldasch https://lnkd.in/emnz8GAZ

Exploring the future of clinical trials in the metaverse - with Aimedis 🏥 Let's delve into how the metaverse could revolutionize clinical trials, paving the way for more efficient and patient-centric research methodologies. Here are a 5 reasons why the metaverse could be your next destination for conducting and collaborating on future research 🔮 1️⃣ Accessibility and Inclusivity 🌍 In the metaverse, geographical barriers vanish, granting access to a diverse pool of participants regardless of their physical location. This inclusivity ensures a broader representation of demographics, enhancing the generalizability of trial results and addressing disparities in healthcare. 2️⃣ Immersive Simulations 👩🏽⚕️🧬 Imagine walking through virtual hospitals or interacting with 3D representations of biological processes. The metaverse offers immersive simulations that can aid in better understanding complex medical concepts, facilitating enhanced training for healthcare professionals and empowering patients with deeper insights into their conditions. 3️⃣ Real-Time Monitoring and Data Collection 💻 In traditional clinical trials, monitoring participants can be challenging and often relies on intermittent check-ins. However, in the metaverse, continuous real-time monitoring is possible, enabling researchers to gather richer, more comprehensive datasets. This real-time feedback loop enhances safety monitoring and allows for prompt adjustments to study protocols. 4️⃣ Enhanced Engagement and Retention 🧑🏽🤝🧑🏿🧑🏽🤝🧑🏿 Participating in a clinical trial can be daunting for patients, often leading to low retention rates. By leveraging the interactive and engaging nature of the metaverse, researchers can create personalized and gamified experiences, incentivizing participation and improving retention rates. 5️⃣ Cost-Efficiency and Time Savings 💵 Conducting clinical trials in the physical world incurs substantial costs related to infrastructure, travel, and personnel. Transitioning to the metaverse significantly reduces these overheads, making research more cost-effective and accelerating the pace of scientific discovery. 🌟 However, we still have a long way to go - starting with establishing ethical guidelines to ensure a safe and sustainable environment for clinical research in this digital world. By engaging with newer technologies, we can usher in an era of more accessible, inclusive, and efficient research. Join us at the Aimedis Avalon Metaverse in co-creating this exciting future 🚀 #Metaverse #ClinicalTrialsEvolved #Research

Faisal Nawaz

📍 Aimedis is the first medical web3 platform consisting of: 1) Digital health apps for patients 2) Digital health apps for professionals (standards like FHIR, GDPR and HIPAA compliance supported) 3) A blockchain and NFT based data marketplace 4) the world's first healthcare metaverse 🔹 Besides having digital health applications Aimedis goes much further and includes and incentivizes all stake holders including patients, including healthcare institutions, research and the healthcare industy. 🔹 The 4 parts of the platform will connect flawlessly and can make use of the other parts (e.g. medical records inside Avalon, e.g. extracting anonymous data from 1), 2) and 4) and give people the possibility to mainstream and monetize on that data (ALWAYS anonymous, ALWAYS legit) 🤖 Artificial Intelligence is integrated into each of the platform's modules either in form of bots, avatars or routines in the background and is there to 1) generate content 2) build the ecosystem 3) support patients and healthcare professionals 4) navigate 5) teach and educate 6) evaluate data even in real time. ⛓ The blockchain is part of each of the module to a) generate trust and transparency b) keep intellectual property c) reflect payments, right management and smart contracts e.g. for consent. 👉 NFTs are being used as a key and access token, besides make sure a), b) and c) are being kept up while data is handled between parties. 🌐 Avalon, build on the latest Unreal Engine, is being available through client versions for Windows, MacOS, iOS and Android while also being available through pixelstreaming via AWS and Google Cloud. The quality of the graphics serves higher credibility when moving inside a healthcare oriented environment. 🔸 The AIMX token has a strong utility inside this ecosystem to 1) incentivize users 2) improve value through exclusive services 3) USP through higher rewards and lower prices 4) intrinsic motivation to improve data quality, service quality, content quality (e.g. AIMX rewards through LEGIT positive ratings). As a payment token it will offer better prices for services and metaverse infrastructure, advertising. ➡️ The Web3 idea incorporates healthcare and data economy and generates opportunities through its character as an open platform that will generate income, new opportunities to RAISE funds for startups and developing countries' healthcare projects and people. ❇️ Aimedis is an nVidia inception partner and we will adapt Avalon to nVidia omniverse to open content generation, business generation and inclusion to the entire healthcare and 3D developer community all over the world. 🥽 VR and AR are being supported (e.g. Meta Quest 3) and the product shall also be adapted for Apple Vision Pro, but does NOT require VR means it runs on old hospital PCs, phones, tablets and later also a Playstation or XBox. #metaverse #healthcare #AI #medical #medical #doctors #health #eHealth #Web3 #DeSci #VirtualReality #AR #VR #AIMEDIS #AIMX

📍 Our partnership with doctors and clinicians produces the finest decisions for patients. ❇️ Doctors are qualified for making medical decisions and they help patients understand their health and make better choices. ❇️ A partnership of doctors with AI systems improves physician workflow by analyzing large amounts of data, detecting patterns between symptoms and treatment outcomes, and providing alerts when something is out of the ordinary. 🔸 With these tools physicians provide improved and advanced care in less time, which frees them and enables work on other important tasks, consequently advancing the quality of healthcare in general. ℹ️ For more information feel free to join our Telegram group: https://lnkd.in/dBx85en9 #metaverse #healthcare #AI #medicine #medical #doctors #health #ehealth #Web3 #DeSci #NFTs #NFT #VirtualReality #AR #VR #AIMEDIS #AIMX $AIMX #Medtwitter #medstudents #HealthcareRevolution #education #therapies #pharma #HealthTech #MedicalResearch #FutureOfMedicine #biotech

Metric
Company Name	Aimedis	MedTech World
Symbol
MSH ID	COM:AIMEDIS	WORLD:MED-TECH
Market	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Commercial & Professional Services
Industry	Health Technology	Event Management
Country	NL	MT
Stage
Employee Count
Website	aimedis.com	med-tech.world
LinkedIn	aimedis	mtw-medtech-world
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

AIME

COM:AIMEDIS

Aimedis

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue